ARKG vs. ARKF
ARKG (ARK Genomic Revolution Multi-Sector ETF) and ARKF (ARK Fintech Innovation ETF) are both exchange-traded funds - ARKG is a Health & Biotech Equities fund actively managed by ARK, while ARKF is a Blockchain fund actively managed by ARK. Both are actively managed. Over the past 5 years, ARKG returned -15.72%/yr vs -4.19%/yr for ARKF. A 0.75 correlation means they provide meaningful diversification when combined. Both charge a 0.75% expense ratio.
Performance
ARKG vs. ARKF - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARKG achieves a 17.09% return, which is significantly higher than ARKF's -16.17% return.
ARKG
- 1D
- -0.24%
- 1M
- 10.92%
- YTD
- 17.09%
- 6M
- 10.02%
- 1Y
- 53.35%
- 3Y*
- 0.67%
- 5Y*
- -15.72%
- 10Y*
- 7.22%
ARKF
- 1D
- -3.76%
- 1M
- -7.12%
- YTD
- -16.17%
- 6M
- -20.39%
- 1Y
- -4.73%
- 3Y*
- 26.10%
- 5Y*
- -4.19%
- 10Y*
- —
ARKG vs. ARKF - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 17.09% | 23.04% | -28.24% | 16.22% | -53.90% | -33.92% | 180.40% | 20.90% |
ARKF ARK Fintech Innovation ETF | -16.17% | 28.67% | 34.34% | 93.27% | -65.07% | -17.82% | 108.03% | 19.04% |
Correlation
The correlation between ARKG and ARKF is 0.61, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.61 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.68 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.76 |
Correlation (All Time) Calculated using the full available price history since Feb 5, 2019 | 0.75 |
The correlation between ARKG and ARKF shifts across timeframes, from 0.61 (1 year) to 0.76 (5 years), reflecting how their relationship changes across market environments.
ARKG vs. ARKF - Sectors Allocation Comparison
Sectors
ARKG
ARKF
Healthcare
Financial Services
Basic Materials
-
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
Utilities
-
-
Healthcare
ARKG
ARKF
Financial Services
ARKG
ARKF
Basic Materials
ARKG
-
ARKF
-
Communication Services
ARKG
-
ARKF
Consumer Cyclical
ARKG
-
ARKF
Consumer Defensive
ARKG
-
ARKF
-
Energy
ARKG
-
ARKF
-
Industrials
ARKG
-
ARKF
-
Real Estate
ARKG
-
ARKF
-
Technology
ARKG
-
ARKF
Utilities
ARKG
-
ARKF
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARKG vs. ARKF — Risk / Return Rank
ARKG
ARKF
ARKG vs. ARKF - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and ARK Fintech Innovation ETF (ARKF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ARKG | ARKF | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.45 | ||
| Sortino ratioReturn per unit of downside risk | +1.95 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.00 | +0.22 |
| Calmar ratioReturn relative to maximum drawdown | 1.95 | -0.12 | +2.07 |
| Martin ratioReturn relative to average drawdown | 4.67 | -0.23 | +4.90 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ARKG | ARKF | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.31 | -0.14 | +1.45 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.35 | -0.10 | -0.25 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.18 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.13 | 0.25 | -0.12 |
Drawdowns
ARKG vs. ARKF - Drawdown Comparison
The maximum ARKG drawdown since its inception was -83.59%, which is greater than ARKF's maximum drawdown of -78.63%. Use the drawdown chart below to compare losses from any high point for ARKG and ARKF.
Loading charts...
Drawdown Indicators
| ARKG | ARKF | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.59% | -78.63% | -4.96% |
Max Drawdown (1Y)Largest decline over 1 year | -27.51% | -38.50% | +10.99% |
Max Drawdown (3Y)Largest decline over 3 years | -51.96% | -38.50% | -13.46% |
Max Drawdown (5Y)Largest decline over 5 years | -80.18% | -75.30% | -4.88% |
Max Drawdown (10Y)Largest decline over 10 years | -83.59% | — | — |
Current DrawdownCurrent decline from peak | -69.65% | -37.16% | -32.49% |
Average DrawdownAverage peak-to-trough decline | -35.87% | -34.96% | -0.91% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.46% | 20.22% | -8.76% |
Volatility
ARKG vs. ARKF - Volatility Comparison
ARK Genomic Revolution Multi-Sector ETF (ARKG) has a higher volatility of 11.90% compared to ARK Fintech Innovation ETF (ARKF) at 8.36%. This indicates that ARKG's price experiences larger fluctuations and is considered to be riskier than ARKF based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARKG | ARKF | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.90% | 8.36% | +3.54% |
Volatility (6M)Calculated over the trailing 6-month period | 28.77% | 24.47% | +4.30% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.12% | 33.66% | +7.46% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 45.61% | 42.79% | +2.82% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.12% | 39.77% | +1.35% |
ARKG vs. ARKF - Expense Ratio Comparison
Both ARKG and ARKF have an expense ratio of 0.75%.
Dividends
ARKG vs. ARKF - Dividend Comparison
ARKG has not paid dividends to shareholders, while ARKF's dividend yield for the trailing twelve months is around 0.11%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
ARKF ARK Fintech Innovation ETF | 0.11% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.37% | 1.25% | 0.00% | 0.00% |
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 0.82% | 1.34% |
Frequently Asked Questions
ARKG and ARKF have a correlation of 0.61, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARKG has higher volatility (11.90%) compared to ARKF (8.36%). In terms of maximum drawdown, ARKG dropped -83.59% vs ARKF's -78.63%.
On 5-year performance, ARKF leads with -4.19% vs -15.72% for ARKG. Both ETFs have the same 0.75% expense ratio. On volatility, ARKF has been the lower-risk option at 8.36%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, ARKF has performed better with a -4.19% return vs -15.72%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
ARKG and ARKF have the same expense ratio: 0.75% per year.
ARKF has the higher dividend yield at 0.11%, compared with 0.00% for ARKG.
ARKG is categorized as Health & Biotech Equities, while ARKF is Blockchain.
ARKG currently has the higher Sharpe Ratio (1.31 vs -0.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ARKG and ARKF
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer